Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595939 | SCV000708392 | uncertain significance | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763873 | SCV000894808 | uncertain significance | Bile acid malabsorption, primary, 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000595939 | SCV001037235 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000595939 | SCV005409637 | uncertain significance | not provided | 2024-08-05 | criteria provided, single submitter | clinical testing | BP4_moderate |
Prevention |
RCV003962724 | SCV004786268 | likely benign | SLC10A2-related disorder | 2022-03-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |